Abstract
Development and validation of rp-hplc method for the simultaneous estimation of montelukast sodium and ebastine in tablet dosage form
1Parul Institute of Pharmacy, P. O. Limda, Waghodia, Vadodara-391 760, India 2Parul Institute of Pharmacy and Research, P. O. Limda, Waghodia, Vadodara-391 760, India
Correspondence Address:
Correspondence Address: N S Rana Parul Institute of Pharmacy, P. O. Limda, Waghodia, Vadodara-391 760 India E‑mail: rananikesh@ymail.com
A rapid and sensitive RP-HPLC method with UV detection (244 nm) for routine analysis of montelukast sodium and ebastine in a pharmaceutical formulation (Ebast-M) was developed. Chromatography was performed with mobile phase containing a mixture of methanol:acetonitrile:ammonium acetate (80:10:10, % v/v/v), pH of mobile phase was adjusted 5.5 using glacial acetic acid and flow rate was 1.2 ml/min. The method was validated for linearity, accuracy, robustness and intermediate precision. The linearity was established over the concentration range of 0.01−0.06 mg/ml for both drugs. The correlation coefficients (r 2) for ebastine and montelukast were 0.9989 and 0.9955, respectively. Statistical analysis of the data showed that the method was precise, accurate, reproducible and selective for the analysis of ebastine and montelukast drugs. The method was successfully employed for the determination of ebastine and montelukast in commercially available tablet dosage form.
